Arsenic trioxide in front-line therapy of acute promyelocytic leukemia (C9710): prognostic significance of FLT3 mutations and complex karyotype

The addition of arsenic trioxide (ATO) to frontline therapy of acute promyelocytic leukemia (APL) has been shown to result in significant improvements in disease-free survival (DFS). FLT3 mutations are frequently observed in APL, but its prognostic significance remains unclear. We analyzed 245 newly...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Leuk Lymphoma
Egile Nagusiak: Poiré, Xavier, Moser, Barry K., Gallagher, Robert E., Laumann, Kristina, Bloomfield, Clara D., Powell, Bayard L., Koval, Gregory, Gulati, Kabir, Holowka, Nicholas, Larson, Richard A., Tallman, Martin S., Appelbaum, Frederick R., Sher, Dorie, Willman, Cheryl, Paietta, Elisabeth, Stock, Wendy
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2014
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4273565/
https://ncbi.nlm.nih.gov/pubmed/24160850
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/10428194.2013.842985
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak